Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Previous revision
cl:0-autoimmune-encephalitis:hashimotos [on August 26, 2019]
cl:0-autoimmune-encephalitis:hashimotos [on August 26, 2019]
Line 25: Line 25:
 The clinical presentation of HE can include seizures, myoclonus, hallucinations,​ and stroke-like episodes with normal or non-specific CSF and brain MRI abnormalities. The clinical presentation of HE can include seizures, myoclonus, hallucinations,​ and stroke-like episodes with normal or non-specific CSF and brain MRI abnormalities.
 </​callout>​ </​callout>​
 +<callout type="​question"​ title="​Controversial Diagnosis"​ icon="​true">​
 +Hashimoto’s encephalopathy should be diagnosed only when a thorough clinical assessment has been performed, including comprehensive testing for well characterized neuronal antibodies, and ruling out other potential causes of encephalopathy or encephalitis. In essence, it should be a diagnosis of exclusion.</​callout>​
 </​WRAP>​ </​WRAP>​
 </​WRAP>​ </​WRAP>​
Line 37: Line 39:
 </​WRAP>​ </​WRAP>​
 <WRAP half column> <WRAP half column>
-<callout type="​warning"​ title="​Antibodies Are Non-Specific!"​ icon="​true">​+<callout type="​warning"​ title="​Thyroid ​Antibodies Are Non-Specific!"​ icon="​true">​
 Thyroid antibodies are not specific for Hashimoto’s encephalopathy. They can be present in up to 13% of healthy individuals,​ and up to 27% in white women older than 60 years. It can also be present in other autoimmune encephalitis disorders. Thyroid antibodies are not specific for Hashimoto’s encephalopathy. They can be present in up to 13% of healthy individuals,​ and up to 27% in white women older than 60 years. It can also be present in other autoimmune encephalitis disorders.
 </​callout>​ </​callout>​